Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development expense	$ 51,054	$ 9,048
General and administrative	18,663	3,846
Total operating expenses	69,717	12,894
Loss from operations	(69,717)	(12,894)
Other (expense) income:
Interest income	23	66
Service fee income from related party	181
Change in fair value of derivative liability	(6,231)
Total other (expense) income	(6,027)	66
Loss from equity method investment in joint venture	(231)
Net loss and comprehensive loss	$ (75,975)	$ (12,828)
Net loss per common share - basic and diluted	$ (8.95)	$ (12.45)
Weighted average shares of common stock outstanding - basic and diluted	8,493,273	1,030,556